Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.
about
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.Importance of FISH genetics in light chain amyloidosis.New concepts in the treatment and diagnosis of amyloidosis.Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.Light Chain Amyloidosis.Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.Novel Therapies in Light Chain Amyloidosis.
P2860
Q38376616-C99A5B20-61FC-45CE-BE21-A26555FC3AE8Q40274316-DD9C5DEB-26C6-4141-82E3-4909A6C71099Q40362742-0A0D525A-1A7B-4FC5-B804-81352A9E31CFQ47135025-B6D75718-CD1B-4C9B-A923-4B61193DB2B6Q47561519-C44AB343-E042-46FD-9C71-2F09FF9F2844Q48140288-1E97351E-67D5-4F44-9519-80A57722FC78Q52659305-B005BAE8-C42A-4530-A3EC-936AE5F4491BQ55023498-4C88B0DE-C63F-413A-9C85-66E66FEE6F7EQ55127439-DDD888D2-63E8-4E52-98CF-BB8E6AA82A28
P2860
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Interphase fluorescence in sit ...... y type and treatment category.
@en
Interphase fluorescence in sit ...... y type and treatment category.
@nl
type
label
Interphase fluorescence in sit ...... y type and treatment category.
@en
Interphase fluorescence in sit ...... y type and treatment category.
@nl
prefLabel
Interphase fluorescence in sit ...... y type and treatment category.
@en
Interphase fluorescence in sit ...... y type and treatment category.
@nl
P2093
P2860
P50
P356
P1433
P1476
Interphase fluorescence in sit ...... y type and treatment category.
@en
P2093
R Chakraborty
P2860
P2888
P304
P356
10.1038/LEU.2016.369
P577
2016-12-01T00:00:00Z